期刊文献+

血清MIF水平与缺血性脑卒中关系的meta分析 被引量:1

Meta Analysis on the Relationship Between Serum MIF Level and Ischemic Stroke
下载PDF
导出
摘要 目的:综合评价血清巨噬细胞移动抑制因子水平与缺血性脑卒中的关系。方法:分别以"血清巨噬细胞移动抑制因子"与"脑卒中、脑血管病、脑梗死、脑栓塞"其中之一结合以主题或关键词或题名检索中国生物医学文献数据库(CMB)、中国学术期刊全文数据库(CNKI)、万方医学数据库、重庆维普数据库;以"macrophage migration inhibitory factor"或"MIF"与"Stroke"、"Cerebrovascular Disease"、"Cerebral Infarction"、"Cerebral Embolism"其中之一结合检索Medline、Pubmed等外文数据库,收集2014年11月以前国内外公开发表的有关中国人血清巨噬细胞移动抑制因子水平与缺血性脑卒中关系的研究文献。按照纳入与排除标准,共纳入9篇文献进行Meta分析。结果:总体效应检验Z=0.20,P=0.84,均数差(SMD)为0.05,95%CI:-0.45^-0.56。I 2>50%,按颈部动脉硬化有无及病程进展进行亚组分析。分析结果显示,AS亚组均数差(SMD)为0.71,95%CI:0.41~1.00,提示血清巨噬细胞移动抑制因子水平升高可能增加发生缺血性脑卒中的危险;进展亚组均数差(SMD)为-0.65,95%CI:-0.98^-0.33,提示血清巨噬细胞移动抑制因子水平降低可能影响IS的严重程度。结论:血清巨噬细胞移动抑制因子水平与缺血性脑卒中的发生有关,巨噬细胞移动抑制因子可能是缺血性脑卒中炎症反应和病情变化的血清标记物之一。 Objective: o evaluate the relationship between serum MIF level and IS. Methods: Papers about the relationship between serum MIF level and IS published before November 2014 were retrieved and collected from CMB,CNKI,Wang Fang,CQVip,Medline,Pubmed and so on. According to inclusion and exclusion criteria,a total of 9 related papers were suitable for meta- analysis. Results These papers were inhomogeneous and then a random effect modem was used. Overall effect Z was 0. 20( P = 0. 84),SMD was 0. 05( 95% CI:- 0. 45 ^- 0. 56) through meta- analysis. Subgroups analyses were carried out according to the neck atherosclerosis or and progression. SMD was 0. 71( 95% CI: 0. 41 ~ 1. 00) in AS subgroup and- 0. 65( 95% CI:- 0. 98 ^- 0. 33) in period subgroup.Conclusion: Serum MIF level was related to IS and selected as one marker to predict inflammation and progress in IS.
出处 《牡丹江医学院学报》 2015年第1期5-9,共5页 Journal of Mudanjiang Medical University
基金 国家自然科学基金项目(81072370) 2014年黑龙江省大学生创新创业训练重点项目
关键词 缺血性脑卒中 巨噬细胞移动抑制因子 META分析 ischemic stroke MIF Meta analysis
  • 相关文献

参考文献19

二级参考文献47

  • 1成文利,胡素华,叶雪妍.2型糖尿病患者血清超敏C反应蛋白检测的临床价值[J].热带医学杂志,2006,6(8):892-894. 被引量:12
  • 2各类脑血管疾病诊断要点[J].中华神经科杂志,1996,29(6):379-380. 被引量:33041
  • 3马桂贤,王丽娟,单志新,林秋雄,张雄,王硕,刘新通.脑梗死患者外周血巨噬细胞移动抑制因子的表达[J].中华神经科杂志,2006,39(12):852-853. 被引量:5
  • 4Krupinski J, Turu MM, Slevin M, et al. Carotid plaque, stroke pathogenesis, and CRP: treatment of ischemic stroke [J]. Curr Cardiol Rep, 2008,10( 1 ) : 25-30.
  • 5Singh SK, Suresh MV, Voleti B, et al. The connection between C-reactive protein and atherosclerosis [J]. Ann Med, 2008,40(2) : 110-120.
  • 6Heinrich J, Schulte H, Schonfeld R, et al. Association of variables of coagulation, fibrinolysis and acute-phase with atherosclerosis in coronary and peripheral arteries and those arteries supplying the brain [J]. Thromb Haemost, 1995,73 (3) : 374-379.
  • 7Pence S, Yilmaz G, Yilmaz N, et al. Determination of plasma fibronectin and serum C-reactive protein in patients with cerebrovascular events [J]. Int J Clin Pract, 2003,57 (2) :91-95.
  • 8Dirnagl U, Iadecola C, Moskowitz MA. Pathobiology of ischaemic stroke: an integrated view [J]. Trends Neurosci, 1999,22 (9) : 391-397.
  • 9Hoi AY, Iskander MN, Morand EF. Macrophage migration inhibitory factor: a therapeutic target across inflammatory diseases [ J ]. Inflamm Allergy Drug Targets, 2007,6 (3) : 183-190.
  • 10Schrans-Stassen BH, Lue H, Sonnemans DG, et al. Stimulation of vascular smooth muscle cell migration by macrophage migration inhibitory factor [J]. Antioxid Redox Signal, 2005,7(9-10) : 1211-1216.

共引文献88

同被引文献16

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部